Recent Updates
Recently added Catalysts
RLAY Positive Sentiment

Relay Therapeutics to Announce Third Quarter 2024 Financial Results and Corporate Highlights on November 6, 2024

Wednesday, October 30, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Relay Therapeutics, a clinical-stage precision medicine company, will announce its third quarter 2024 financial results along with corporate highlights. The report is scheduled for November 6, 2024, after U.S. financial markets close. This announcement reflects the company's ongoing efforts in drug discovery and investor communication.
Price reaction · baseline $5.9 (2024-10-29 close) · hit after-hours · clean, no other RLAY news in the window
day 0 close · peak
-3.2%

Market Sentiment Analysis

POSITIVE FACTORS

  • Relay Therapeutics is set to report its financial results and corporate highlights, indicating progress.
  • The announcement shows the company's commitment to transparency and investor engagement.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+284%
120-day peak, hindsight
Typical move
11.8%
average across 6 past catalysts
Cash runway
~50 mo
Minimal dilution risk
Lead asset
RLY-8161
Phase 1 · Advanced NRAS-Mutant Melanoma

Full Press Release Details

CAMBRIDGE, Mass., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY), a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies, will report third quarter 2024 financial results and corporate highlights after the U.S. financial markets close on Wednesday, November 6, 2024.
About Relay Therapeutics

Frequently Asked Questions

When will Relay Therapeutics report Q3 2024 financial results?

Relay Therapeutics will report its Q3 2024 financial results on November 6, 2024.

What does Relay Therapeutics focus on?

Relay Therapeutics focuses on precision medicine in drug discovery.

How does Relay Therapeutics enhance drug discovery?

They combine advanced computational and experimental technologies.

Where is Relay Therapeutics located?

Relay Therapeutics is located in Cambridge, Massachusetts.

ShareAdd on Google
Tags: RLAY Viatris Investor Conferences Healthcare Relay Therapeutics financial results Q3 2024 precision medicine
Last updated: Oct 30, 2024

Biotech snapshot

Cash runway
$911M liquidity · $18M/mo burn
~50 mo
Minimal dilution risk
Lead asset
RLY-8161Phase 1
Advanced NRAS-Mutant Melanoma →

Catalyst track record

+284%
best trade around RLAY's most recent catalyst

Peak hindsight return over a 120-day window, across 6 tracked FDA/PDUFA catalysts for RLAY.

See every catalyst's timing & PoA →